Model Driven Diabetes Care (MDDC)
Data Driven Feedback as a Method to Improve Glycaemic Control in Type 1 Diabetes
調査の概要
詳細な説明
All patients will be given access to a mobile phone with the diabetes diary known as the Few Touch Application (FTA) installed. They may use either their own compatible Android handsets, or provided handsets. The study uses a delayed start design. Participants are randomized into two groups, who get access to the module "Diastat" after 4 and 12 weeks post-enrollment respectively. Each group uses the FTA with Diastat for 8 weeks post-intervention (i.e. access to Diastat).
Diastat is a module within FTA that provides data-driven feedback to the patients using their own data. This module is based on the data recorded in a previous trial [1]. Three submodules are part of Diastat; Periodicity detection and visualization, multiscale trend detection based on the c-SiZer algorithm [2], and situation matching for insulin dosage [3].
- Skrøvseth SO et al, Diabetes Technol Ther (2012)
- Skrøvseth SO et al, PLoS ONE (2012)
- Skrøvseth SO et al, Accepted for Advanced Technologies and Treatments for Diabetes, Paris, France, 2013.
研究の種類
入学 (実際)
段階
- 適用できない
連絡先と場所
研究場所
-
-
-
Tromsø、ノルウェー、9038
- University Hopital of North Norway
-
-
参加基準
適格基準
就学可能な年齢
健康ボランティアの受け入れ
受講資格のある性別
説明
Inclusion Criteria:
- Confirmed diagnosis with Diabetes Mellitus type 1 for at least one year.
- Age over 18 years
- Has basic familiarity with mobile phones, and uses mobile phone on a daily basis.
Exclusion Criteria:
- Severe complications due to their diabetes.
- Unable to understand or conform to the guidelines when presented with the phone's software.
研究計画
研究はどのように設計されていますか?
デザインの詳細
- 主な目的:支持療法
- 割り当て:ランダム化
- 介入モデル:並列代入
- マスキング:なし(オープンラベル)
武器と介入
参加者グループ / アーム |
介入・治療 |
---|---|
アクティブコンパレータ:Delayed Diastat
Mobile phone application Few Touch Application (FTA) in the regular version, with Diastat turned on in week 12 post-enrollment.
|
Users get access to the regular version of the Few Touch Application for Type 1 Diabetes.
他の名前:
Users get the Few Touch Application with Diastat module activated.
|
実験的:Diastat
Few Touch Application with Diastat module turned on in week 4 post-enrollment.
|
Users get access to the regular version of the Few Touch Application for Type 1 Diabetes.
他の名前:
Users get the Few Touch Application with Diastat module activated.
|
この研究は何を測定していますか?
主要な結果の測定
結果測定 |
メジャーの説明 |
時間枠 |
---|---|---|
Change in the Frequency of Hyper- and Hypo-glycemic Events From Baseline to Week 8-12.
時間枠:Up to 12 weeks post-enrollment
|
The number of self-measured blood glucose values < 4 mmol/L (72 mg/dL) or > 15 mmol/L (270 mg/dL) will be recorded during baseline (first 4 weeks post-enrollment/start of study) and during weeks 8-12 post-enrollment for all participants.
|
Up to 12 weeks post-enrollment
|
二次結果の測定
結果測定 |
メジャーの説明 |
時間枠 |
---|---|---|
Change in HbA1c
時間枠:up to 20 weeks post-enrollment
|
HbA1c will be measured at the start of the study (week 1 post-enrollment) and during the last week of intervention (week 12 for the intervention group and week 20 for the active comparator group).
|
up to 20 weeks post-enrollment
|
その他の成果指標
結果測定 |
メジャーの説明 |
時間枠 |
---|---|---|
Usability
時間枠:up to 20 weeks post-enrollment
|
System Usability Scale (SUS) will be applied to assess usability of the approach and recorded during the last week of intervention (week 12 for the intervention group and week 20 for the active comparator group).
|
up to 20 weeks post-enrollment
|
Empowerment
時間枠:Up to 12 weeks post-enrollment.
|
Diabetes Empowerment Scale-Short Form (DES-SF) will be used to assess empowerment at the start of the study (week 1 post-enrollment) and during week 12 of intervention.
|
Up to 12 weeks post-enrollment.
|
協力者と研究者
捜査官
- 主任研究者:Stein Olav Skrøvseth, PhD、University Hospital of North Norway
出版物と役立つリンク
一般刊行物
- Skrovseth SO, Arsand E, Godtliebsen F, Hartvigsen G. Mobile phone-based pattern recognition and data analysis for patients with type 1 diabetes. Diabetes Technol Ther. 2012 Dec;14(12):1098-104. doi: 10.1089/dia.2012.0160. Epub 2012 Oct 4.
- Skrovseth SO, Arsand E, Godtliebsen F, Joakimsen RM. Model driven mobile care for patients with type 1 diabetes. Stud Health Technol Inform. 2012;180:1045-9.
- Arsand E, Froisland DH, Skrovseth SO, Chomutare T, Tatara N, Hartvigsen G, Tufano JT. Mobile health applications to assist patients with diabetes: lessons learned and design implications. J Diabetes Sci Technol. 2012 Sep 1;6(5):1197-206. doi: 10.1177/193229681200600525.
- Skrovseth SO, Bellika JG, Godtliebsen F. Causality in scale space as an approach to change detection. PLoS One. 2012;7(12):e52253. doi: 10.1371/journal.pone.0052253. Epub 2012 Dec 27.
- Skrovseth SO, Arsand E, Godtliebsen F, Joakimsen RM. Model-driven diabetes care: study protocol for a randomized controlled trial. Trials. 2013 May 14;14:139. doi: 10.1186/1745-6215-14-139.
- Skrovseth SO, Arsand E, Godtliebsen F, Joakimsen RM. Data-Driven Personalized Feedback to Patients with Type 1 Diabetes: A Randomized Trial. Diabetes Technol Ther. 2015 Jul;17(7):482-9. doi: 10.1089/dia.2014.0276. Epub 2015 Mar 9.
研究記録日
主要日程の研究
研究開始
一次修了 (実際)
研究の完了 (実際)
試験登録日
最初に提出
QC基準を満たした最初の提出物
最初の投稿 (見積もり)
学習記録の更新
投稿された最後の更新 (見積もり)
QC基準を満たした最後の更新が送信されました
最終確認日
詳しくは
この情報は、Web サイト clinicaltrials.gov から変更なしで直接取得したものです。研究の詳細を変更、削除、または更新するリクエストがある場合は、register@clinicaltrials.gov。 までご連絡ください。 clinicaltrials.gov に変更が加えられるとすぐに、ウェブサイトでも自動的に更新されます。
Few Touch Applicationの臨床試験
-
University Hospital of North NorwayThe Research Council of Norway; European Commission; Oslo University College完了
-
Smith & Nephew, Inc.完了
-
University Hospital Inselspital, BerneDeka Medical, Inc.積極的、募集していない
-
Pacira CryoTech, Inc., a wholly owned subsidiary...完了
-
Schulthess Klinik完了関節疾患 | 変形性関節症 | 筋骨格系の疾患または状態 | 変形性関節症 親指 | 第一手根中手関節の関節症スイス
-
Hopital Nord Franche-Comte積極的、募集していない
-
National and Kapodistrian University of AthensIRCCS San Raffaeleわからない